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Neoplastic disorders are one of the most widely spread
diseases over the world. There are more than 1 million
new cases of cancer registered in the world every year.
Therefore, searching for new potential antineoplastic
agents is very important task. Computer-aided approaches
are widely used for this purpose. To find new agents pos-
sessing the required activities, we used a computer pro-
gram PASS. PASS simultaneously predicts more than 2800
pharmacological effects, mechanisms of action and spe-
cific toxicities (so called biological activity spectrum)
based on structural formula of the compound. As a result,
PASS estimates probability of presence of selected biolog-
ical activities. The method has 93% average accuracy of
prediction (leave-one-out cross-validation – LOO CV)
and is robust to the incompleteness of data (http://
www.ibmc.msk.ru/pass). More than 200 anticancer
mechanisms of actions are currently included into PASS
knowledgebase. To improve the quality of prediction, we
collected more than 5000 chemical compounds with anti-
cancer activities. This data were added to the training set
of PASS. The mean accuracy of prediction for anticancer
activities was 90% (LOO CV). PASS was applied to analy-
sis of compounds from databases of commercially availa-
ble samples. We used three databases from ASINEX,
ChemBridge and InterBioScreen (IBS) together contained
structures of 1565000 compounds. The probability more
than 70% of biological activity was used as a criterion for
selection of potential anticancer agents. The results of
selection are shown in Table 1 below.
We identified more than 230,000 compounds with prob-
ability >70% of presence of 148 anticancer activities. Less
than 40 compounds for each activity were predicted for 70
activities. Less than 20 compounds for each activity were
predicted for 54 activities and less than 10 compounds for
36 activities. These compounds may be tested vs. pre-
dicted activities. Additional selection based of ADME
properties, drug-likeness etc. is necessary for the remain-
ing compounds.
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Table 1
Supplier Number of Compounds Number of selected activities Number of selected compounds
ASINEX 384178 131 69011
CHEMBRIDGE 785622 125 114829
IBS 395200 137 46847
